CynthiaLGayMDMPH

PubMed

• 51 citations
  Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.
  Peter B Gilbert, Yunda Huang, Allan C deCamp, Shelly Karuna, Yuanyuan Zhang
  Nature Medicine. 2022-09-01
• 9 citations
  Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Cli...
  Deborah A Theodore, Angela R Branche, Lily Zhang, Daniel S Graciaa, Madhu Choudhary
  JAMA Network Open. 2023-07-03
• 13 citations
  Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.
  Alfredo J Mena Lora, Jessica E Long, Yunda Huang, Lindsey R Baden, Hana M El Sahly
  JAMA Network Open. 2023-01-03

Journal Articles

• Results of a Social Network Testing Intervention for HIV in Infectious Disease Clinics  
  Aimee Wilkin, Cynthia L Gay, AIDS and Behavior
• Results of a Social Network Testing Intervention for HIV in Infectious Disease Clinics  
  LeViere A, Donovan J, Wilkin A, Keller J, Parnell H, Sampson L, Gay CL, Quinlivan EB, AIDS Behav, 1/5/2018
• Virological and immunological responses to raltegravir and dolutegravir in the gut-associated lymphoid tissue of HIV-infected men and women  
  Weber MD, Andrews E, Prince HA, Sykes C, Rosen EP, Bay C, Shaheen NJ, Madanick RD, Dellon ES, De Paris K, Nelson JA, Gay CL, Kashuba AD, J Clin Invest, 1/1/2018
• T cells establish and maintain CNS viral infection in HIV-infected humanized mice  
  Honeycutt JB, Liao B, Nixon CC, Cleary RA, Thayer WO, Birath SL, Swanson MD, Sheridan P, Zakharova O, Prince F, Kuruc J, Gay CL, Evans C, Eron JJ, Wahl A, Garcia JV, J Clin Invest, 1/1/2018
• Integrating a statewide HIV call line: an innovative and tailored approach for rapid linkage to HIV care  
  Coleman TE, LeViere A, Carcano J, Bailey M, Heine A, Quinlivan EB, Gay C, Journal of the Association of Nurses in AIDS Care, 1/1/2017
• HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities  
  Thompson CG, Gay CL, Kashuba ADM, AIDS Res Hum Retroviruses, 1/1/2017
• Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues  
  Cottrell ML, Garrett KL, Prince HMA, Sykes C, Schauer A, Emerson CW, Peery A, Rooney JF, McCallister S, Gay C, Kashuba ADM, J Antimicrob Chemother, 1/1/2017
• Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells  
  Sung JA, Sholtis K, Kirchherr J, Kuruc JD, Gay CL, Nordstrom JL, Bollard CM, Archin NM, Margolis DM, EBioMedicine, 1/1/2017
• Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency  
  Archin NM, Kirchherr JL, Sung JA, Clutton G, Sholtis K, Xu Y, Allard B, Stuelke E, Kashuba AD, Kuruc JD, Eron J, Gay CL, Goonetilleke N, Margolis DM, J Clin Invest, 1/1/2017
• Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability  
  Gay CL, Willis SJ, Cope AB, Kuruc JD, McGee KS, Sebastian J, Crooks AM, McKellar MS, Margolis DM, Fiscus SA, Hicks CB, Ferrari G, Eron JJ; Duke-UNC Acute HIV Infection..., AIDS, 1/1/2016
• Corrigendum: The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function  
  Clutton G, Xu Y, Baldoni PL, Mollan KR, Kirchherr J, Newhard W, Cox K, Kuruc JD, Kashuba A, Barnard R, Archin N, Gay CL, Hudgens MG, Margolis DM, Goonetilleke N, Sci Rep, 1/1/2016
• Ten Years of Screening and Testing for Acute HIV Infection in North Carolina  
  Kuruc JD, Cope AB, Sampson LA, Gay CL, Ashby RM, Foust EM, Brinson M, Barnhart JE, Margolis D, Miller WC, Leone PA, Eron JJ, J Acquir Immune Defic Syndr, 1/1/2016
• Ongoing HIV Transmission and the HIV Care Continuum in North Carolina  
  Cope AB, Powers KA, Kuruc JD, Leone PA, Anderson JA, Ping LH, Kincer LP, Swanstom R, Mobley VL, Foust E, Gay CL, Eron JJ, Cohen MS, Miller WC, PLoS One, 1/4/2015
• Dual-affinity re-targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells  
  Sung JA, Pickeral J, Liu L, Stanfield-Oakley SA, Lam CK, Garrido C, Pollara J, LaBranche C, Bonsignori M, Moody MA, Yang Y, Parks R, Archin N, Allard B, Kirchherr J, K..., J Clin Invest, 1/1/2015
• Unreported male sex partners among men with newly diagnosed HIV infection - North Carolina, 2011-2013  
  Wu H, Hightow-Weidman LB, Gay CL, Zhang X, Beagle S, Hall L, Jackson T, Marmorino J, Do AN, Peters PJ, MMWR Morb Mortal Wkly Rep, 1/1/2015
• HIV Infection Among Partners of HIV-Infected Black Men Who Have Sex with Men - North Carolina, 2011-2013  
  Peters PJ, Gay C, Beagle S, Shankar A, Switzer WM, Hightow-Weidman LB; Centers for Disease Control and Prevention (CDC), MMWR Morb Mortal Wkly Rep, 1/7/2014
• Detection of acute HIV infection in two evaluations of a new HIV diagnostic testing algorithm � United States, 2011-2013  
  CDC. (Geren K, Moore E, Tomlinson C, Hobohm D, Gardner A, Reardon-Maynard D, Gay C, Hightow-Weidman L, Pandori M, Moss N, Westheimer E, Tsoi B, Branson B, Peters P.), Morb Mortal Wkly Rep, 1/21/2013
• The Multispot rapid HIV-1/HIV-2 differentiation assay is comparable with the Western blot and an immunofluorescence assay at confirming HIV infection in a prospective ...  
  Pandori MW, Westheimer E, Gay C, Moss N, Fu J, Hightow-Weidman LB, Craw J, Hall L, Giancotti FR, Mak ML, Madayag C, Tsoi B, Louie B, Patel P, Owen SM, Peters PJ, J Clin Virol, 1/1/2013
• Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary healthcare clinic in Johannesburg, South Africa  
  Clouse K, Pettifor AE, Maskew M, Bassett J, Van Rie A, Behets F, Gay C, Sanne I, Fox MP, J Acquir Immune Defic Syndr, 1/1/2013
• CD4+CD8+ T Cells Represent a Significant Portion of the Anti-HIV T Cell Response to Acute HIV Infection  
  Frahm MA, Picking RA, Kuruc JD, McGee KS, Gay CG, Eron JJ, Hicks CB, Tomaras GD, Ferrari G, Journal of Immunology, 1/1/2012
• Prospective study of the ARCHITECT HIV Ag/Ab Combo fourth generation assay to detect HIV infection in sexually transmitted infection clinics  
  Bishoff JJ, Kuruc JD, Embry JA, Hatch JE, Ashton FA, Schmitz JL, Miller WC, Leone PA, Gay CL, AIDS, 1/1/2011
• Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection  
  Ferrari G, Korber B, Goonetilleke N, Liu MK, Turnbull EL, Salazar-Gonzalez JF, Hawkins N, Self S, Watson S, Betts MR, Gay CL, McGee K, Pellegrino P, Williams I, Tomara..., PLoS Pathogens, 1/1/2011
• The gap between HIV infection and advances in HIV treatment  
  Gay C, Clin Infect Dis, 1/1/2010
• Acute HIV infection: the impact of anti-retroviral treatment on cellular immune responses  
  Hicks CB, Gay C, Ferrari G, Clin Exp Immunol, 1/1/2007
• Antiretroviral therapy for prevention of the sexual transmission of HIV-1  
  Cohen MS, Gay C, Kashuba A, Blower S, Paxton L, Annals of Internal Medicine, 1/1/2007
• Join now to see all

Books/Book Chapters

• UpToDate 
  Chapter: Prevention of sexually transmitted diseases, Parts 1 and 2 
  Gay C and Cohen MSEditors: Rose, BD.Waltham, MA2017
• HIV Prevention 
  Chapter: Using Antiretrovirals to Prevent HIV Transmission 
  Gay C, Kashuba A and Cohen MEditors: Pizer H and Mayer K.2008
• Netter�s Internal Medicine 
  Chapter: Encephalitis 
  Gay C and Eron JEditors: Runge M and Greganti M.Saunders Elsevier, Philadelphia, PAEdition 2nd,2008
• Netter�s Internal Medicine 
  Chapter: Sepsis 
  Eron J and Gay CEditors: Runge M and Greganti M.Saunders Elsevier, Philadelphia, PAEdition 2nd,2008
• Netter�s Internal Medicine 
  Chapter: Fever of Unknown Origin 
  Miller W and Gay CEditors: Runge M and Greganti M.Saunders Elsevier, Philadelphia, PAEdition 2nd,2008
• DynaMed 
  Chapter: Acute HIV Infection 
  Gay CEBSCO Industries, Inc., Ipswich, MA
• Join now to see all

Abstracts/Posters

• Near full-length sequence analysis reveals no evidence of HIV-1 replication during therapy
  Lee SK, Rogers A, Xu Y, Warren J, Goonetilleke N, Zhou S, Pond SK, Bednar M, Hauser B, Gay C, Kuruc J, Archin N, Eron J, Margolis D, Swanstrom R, 22nd International AIDS Conference, Amsterdam, Netherlands, 1/23/2018
• Altered TDF/FTC pharmacology in a transgender female cohort: Implications for PreP
  Cottrell, ML, Prince HM, Maffuid K, Poliseno A, White N, Sykes C, Nelson JA, Peery A, Dellon E, Hightow-Weidman L, Adams JL, Gay C, Kashuba A, 22nd International AIDS Conference, Amsterdam, Netherlands, 1/23/2018
• Comparing time to viral suppression among acute and non-acute HIV in North Carolina
  Adams DA, Cope A, Wheeler B, Mobley V, Barnhart J, Kuruc JD, Gay CL, Filiatreau LM, Ashby R, Samoff E, Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/4/2018
• Differential antiretroviral localization and drug transporter expression within gut-associated lymphoid tissue of HIV+ subjects: comparison to pre-clinical species
  Thompson CG, Prince HA, Fallon JK, Rosen EP, Sykes C, Mathews M, Arora S, Dellon ES, Peery A, Shaheen N, Gay C, Luciw PA, Akkina R, Garcia JV, Smith PC, Kashuba ADM, 9th IAS Conference on HIV Science, Paris, France, 1/23/2017
• Vorinostat renders the replication-competent latent reservoir of HIV vulnerable to clearance by CD8 T cell
  Sung J, Bednar M, Joseph S, Sholtis K, Kuruc J, Gay C, Swanstrom R, Nordstrom J, Bollard C, Archin N, Margolis D, 9th IAS Conference on HIV Science, Paris, France, 1/23/2017
• Treatment of acute HIV with elvitegravir, cobicistat, emtriciabine and tenofovir
  McGee K, Filiatreau L, Crooks A, Gay C, Kuruc J, Hicks C, Eron J, Margolis DM, Ferrari G, McKellar M, 9th IAS Conference on HIV Science, Paris, France, 1/23/2017
• Evans M, Patala A, Campbell E, Westheimer E, Gay CL, Cohen SE, Switzer WM, Peters PJ, ID Week, San Diego, CA, 1/4/2017
• Phylodynamic analysis aids partner services by identifying unreported transmission
  Campbell E, Shankar A, Westheimer E, Gay CL, Cohen SE, Li JF, Johnson JA, Peters PJ, Switzer WM, Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/4/2017
• Evaluation of Abbott ARCHITECT HIV Combo signal to cutoff ratio and ambiguous nucleotide frequency as markers of HIV infection duration
  Porter S, Lecher S, Shankar A, Westheier E, Gay C, Cohen S, Campbell E, Sigalo N, Rose, Zhou J, Li J, Johnston J, Switzer W, Peters P, ID Week, New Orleans, LA, 1/26/2016
• Safety, immunologic and virologic activity of anti-PD-L1 in HIV-1 participants on ART
  Eron JJ, Gay C, Bosch R, Ritz J, Hataye JM, Hwang C, Tressler RL, Mason SM, Koup RA, Mellors JW, for the ACTG A5326 Study Team, Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/22/2016
• Effect of Acute HIV Infection on CD4/CD8 Normalization After ART Initiation
  Davy T, Napravnik S, Cope A, Kuruc J, Gay C, Eron J, Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/22/2016
• Neurocognitive Improvement With NRTI-Sparing Treatment in Acute HIV Infection
  Gay C, Willis S, Kuruc J, McGee K, Kashuba A, McKellar M, Hicks C, Eron J, Margolis D, Robertson K, Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/22/2016
• Effective Disease Intervention Is Key Component to Acute HIV Detection
  Kuruc J, Willis S, Dzialowy N, Maxwell J, Barnhart J, Mobley V, Gay C, Sarnoff E, Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/22/2016
• Concentrations of TFV and TFVdp in Female Mucosal Tissues After a Single Dose of TAF
  Garrett K, Cottrell M, Prince H, Sykes C, Schauer A, Peery A, Rooney J, McCallister S, Gay C, Kashuba A, CROI, Boston, MA, 1/22/2016
• Care-Cascade Status of Partners of Persons With New HIV Infections in North Carolina
  Cope A, Hightow-Weidman L, Kuruc J, Marmorino J, Beagle S, Gay C, Peters P, Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 1/23/2015
• Cost Effectiveness of Adding 4th-Generation Immunoassay Screening After a Negative Rapid HIV Test
  Hutchinson A, Cohen S, Westheimer E, Gay C, Marseille E, Hall L, Hightow-Weidman L, Tsoi B, Pandori M, Peters P, Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 1/23/2015
• Preliminary Assessment of the Neurocognitive Effects of Vorinostat Administration in HIV Eradication
  Robertson K, Kuruc J, Gay C, Archin N, Eron J, Margolis D, XX International AIDS Conference, Melbourne, Australia, 1/21/2014
• Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated during Acute HIV Infection
  Gay C, Archin N, Tcherepanova I, Villiard E, Hicks C, Kearney M, Coffin J, DeBenedette, M, Eron J, Nicollette C, Margolis DM, 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/2/2014
• Measuring HIV latency over time: reservoir stability and assessing interventions
  Archin N, Crooks A, Bateson R, Cope AB, Dahl NP, Eron JJ, Gay CL, Kuruc JD, Margolis DM, Bosch RJ, 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/2/2014
• Partners of Individuals with Acute HIV Infection have a High Frequency of Known HIV Infection
  Peters PJ, Westheimer E, Cohen S, Rose C, Gay C, Jackson B, Hightow-Weidman LB, Hall L, 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/2/2014
• Cost effectiveness of adding 4th-generation immunoassay screening after a negative rapid HIV test
  Hutchinson A, Cohen S, Westheimer E, Gay C, Marseille E, Hall L, Hightow-Weidman LB, Tsoi B, Pandori M, Peters PJ, 21st Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/2/2014
• Implementation of a Collaborative HIV Testing Model between an Emergency Department and Infectious Disease Clinic
  Hoots BE, Klein PW, Leone PA, Quinlivan EB, Larson JL, Young JE, Miller MB, and Gay CL, JAIDS, 1/1/2014
• HIV Combination Antigen / Antibody Testing Detects a High Proportion of Acute HIV Infections and Improves HIV Diagnostic Yield�Three Regions of the United States
  Peters PJ, Westheimer E, Moss N, Gay C, Tsoi B, Pandori MW, Hightow-Weidman LB, Hall L, Patel P, for the STOP study group, 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 1/3/2013
• �No one�s at home and they won�t pick up the phone�: Using the Internet and SMS to Enhance Partner Services in North Carolina
  Hightow-Weidman LB, Beagle S, Embry J, Pike E, Kuruc J, Leone P, Foust E, Gay C, 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA, 1/3/2013
• Selective HIV RNA screening of specimens that are non-reactive by 4th generation HIV testing can identify additional infections: lessons from the STOP Study
  Moss N, Rose C, Gay C, Hall L, Hightow-Weidman L, Tsoi B, Westheimer E, Peters PJ, Pandori M, ID Week, San Francisco, CA, 1/2/2013
• Join now to see all

Lectures

• Discuss unknown clinical cases using my clinical experience and knowledge of the medical literature 
  University of North Carolina, Chapel Hill, NC - 1/1/2018
• Treatment and Prophylaxis of AIDS Opportunistic Infections 
  Infectious Diseases Boot Camp for incoming ID fellows - 1/1/2018
• Antibodies & HIV Prevention: Thinking Outside the Box and On Target 
  Chapel Hill, NC - 1/21/2016
• Virologic and Immunologic Responses to Raltegravir and Dolutegravir in GALT of HIV+ Men and Women 
  Washington, DC - 1/8/2016
• Management of Acute HIV 
  Chapel Hill, NC - 1/2/2016
• Evaluation of Abbott ARCHITECT HIV Combo signal to cutoff ratio and ambiguous nucleotide frequency as markers of HIV infection duration 
  1/1/2016
• CTL Therapy and HIV 
  Bethesda, MD - 1/10/2014
• An innovative call center linking patients and providers to HIV care 
  Denver, CO - 1/1/2014
• Update on Acute HIV 
  1/21/2013
• HIV � A Global Perspective 
  1/23/2012
• Soft Tissue Infections 
  1/1/2012
• HIV � The Basics 
  1/1/2012
• Antiretroviral Treatment Failure � Clinical Presentations 
  Chapel Hill, NC - 1/14/2011
• Update on the XVIII Conference on Retroviruses and Opportunistic Infections (CROI) 
  Chapel Hill, NC - 1/12/2011
• Outcomes of HIV positive sex workers in inner-city Johannesburg 
  Durban, South Africa - 1/7/2011
• Acute HIV Infection 
  1/1/2011
• The STOP study - new ways to detect AHI and improve partner services 
  1/1/2011
• UNAID�s New Global Strategy: Treatment 2.0 
  Chapel Hill, NC - 1/1/2011
• Update on PMTCT � International AIDS Conference 
  Windhoek, Namibia - 1/1/2010
• Pediatric HIV 
  Kigali, Rwanda and Windhoek, Namibia - 1/1/2010
• HIV-TB Co-infection in Children 
  Kigali, Rwanda and Windhoek, Namibia - 1/1/2010
• Update on WHO Tuberculosis Treatment Guidelines 
  Chapel Hill, NC - 1/1/2010
• HIV Basics: Recognizing Infection and Principals of Therapy 
  Chapel Hill, NC - 1/1/2010
• Striking elevations in systemic and mucosal cytokine and chemokine levels in acute HIV-1 infection 
  Paris, France - 1/19/2009
• Implementation of a collaborative HIV testing model between an emergency department and infectious disease clinic in North Carolina 
  Washington, DC - 1/19/2008
• Join now to see all

Other

• Prevention of sexually transmitted infections 
  Gay CL, Cohen MS
  http://www.uptodate.com/contents/prevention-of-sexually-transmitted-infections
  UpToDate, Wolters Kluwer Health - 2012-11-15
• HIV � A Global Perspective 
  Gay C, UNC Foundations for Global Health Course